GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » Cyclically Adjusted Price-to-FCF

Medipost Co (Medipost Co) Cyclically Adjusted Price-to-FCF : (As of Jun. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medipost Co Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medipost Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Medipost Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Cyclically Adjusted Price-to-FCF Chart

Medipost Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medipost Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medipost Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Medipost Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medipost Co's Cyclically Adjusted Price-to-FCF falls into.



Medipost Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Medipost Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medipost Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.568/118.8477*118.8477
=-0.568

Current CPI (Mar. 2024) = 118.8477.

Medipost Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -1.950 99.353 -2.333
201409 -0.289 99.608 -0.345
201412 -0.494 99.098 -0.592
201503 -0.561 99.720 -0.669
201506 -0.582 100.050 -0.691
201509 -0.303 100.110 -0.360
201512 -0.393 100.220 -0.466
201603 -0.444 100.560 -0.525
201606 -0.612 100.790 -0.722
201609 -0.433 101.460 -0.507
201612 -0.104 101.560 -0.122
201703 -0.264 102.850 -0.305
201706 -0.048 102.610 -0.056
201709 -0.423 103.490 -0.486
201712 -0.203 102.990 -0.234
201803 -0.153 104.100 -0.175
201806 0.097 104.130 0.111
201809 0.157 105.650 0.177
201812 0.468 104.350 0.533
201903 -0.019 104.490 -0.022
201906 0.007 104.880 0.008
201909 0.016 105.200 0.018
201912 0.233 105.120 0.263
202003 -0.689 105.540 -0.776
202006 0.214 104.870 0.243
202009 -0.141 106.200 -0.158
202012 -0.058 105.765 -0.065
202103 -0.082 107.357 -0.091
202106 0.169 107.579 0.187
202109 -0.691 108.759 -0.755
202112 -0.121 109.676 -0.131
202203 -0.419 111.806 -0.445
202206 0.070 114.083 0.073
202209 -0.115 114.831 -0.119
202212 -0.438 115.200 -0.452
202303 -0.479 116.550 -0.488
202306 -0.553 117.140 -0.561
202309 -0.340 119.111 -0.339
202312 -0.768 118.848 -0.768
202403 -0.568 118.848 -0.568

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medipost Co  (OTCPK:MEPTF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Medipost Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Medipost Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (Medipost Co) Business Description

Industry
Traded in Other Exchanges
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines